Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Lightchain Capital LLC, founded in 2018 by Rodger Riney, is based in St. Louis, Missouri. This venture capital fund operates as a family office, focusing on early-stage investments in life sciences. The firm specifically targets advancements in treatments for multiple myeloma and related cancers.
The fund primarily invests in early-stage life sciences and software companies, particularly those improving cancer patient outcomes. Lightchain Capital looks for opportunities that require multiple financing rounds and collaborations, emphasizing scientific cancer research.
Notable portfolio companies include C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company; Geneoscopy, Inc., focused on non-invasive diagnostics; NextRNA Therapeutics, working on RNA-targeted therapeutics; Wugen, developing therapies for cancer treatment; CareVet, a veterinary practice management group; AI Proteins, designing therapeutic proteins using AI; and Simple Rose, providing applications for scheduling and production planning.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.